Evidence map›Paper›PMID 25289695›Full record

ArticlePloS one2014

Regulation of the tyrosine phosphorylation of Phospholipid Scramblase 1 in mast cells that are stimulated through the high-affinity IgE receptor.

Asma Kassas, Ivan C Moura, Yumi Yamashita, Jorg Scheffel, Claudine Guérin-Marchand, Ulrich Blank, Peter J Sims, Therese Wiedmer, Renato C Monteiro, Juan Rivera and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Proteomic Analysis of Lipid Rafts from RBL-2H3 Mast Cells.International journal of molecular sciences · 2019
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Asma KassasINSERM U1149, Faculté de Médecine Xavier Bichat, Paris, France; University Paris-Diderot, Sorbonne Paris Cité, Laboratoire d'excellence INFLAMEX, DHU FIRE, Paris, France.
Ivan C MouraINSERM U1149, Faculté de Médecine Xavier Bichat, Paris, France; University Paris-Diderot, Sorbonne Paris Cité, Laboratoire d'excellence INFLAMEX, DHU FIRE, Paris, France.
Yumi YamashitaLaboratory of Molecular Immunogenetics, Molecular Immunology and Inflammation Branch, NIAMSD, NIH, Bethesda, Maryland, United States of America.
Jorg ScheffelLaboratory of Molecular Immunogenetics, Molecular Immunology and Inflammation Branch, NIAMSD, NIH, Bethesda, Maryland, United States of America.
Claudine Guérin-MarchandINSERM U1149, Faculté de Médecine Xavier Bichat, Paris, France; University Paris-Diderot, Sorbonne Paris Cité, Laboratoire d'excellence INFLAMEX, DHU FIRE, Paris, France.
Ulrich BlankINSERM U1149, Faculté de Médecine Xavier Bichat, Paris, France; University Paris-Diderot, Sorbonne Paris Cité, Laboratoire d'excellence INFLAMEX, DHU FIRE, Paris, France.
Peter J SimsDepartment of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America.
Therese WiedmerDepartment of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America.
Renato C MonteiroINSERM U1149, Faculté de Médecine Xavier Bichat, Paris, France; University Paris-Diderot, Sorbonne Paris Cité, Laboratoire d'excellence INFLAMEX, DHU FIRE, Paris, France.
Juan RiveraLaboratory of Molecular Immunogenetics, Molecular Immunology and Inflammation Branch, NIAMSD, NIH, Bethesda, Maryland, United States of America.
Nicolas CharlesINSERM U1149, Faculté de Médecine Xavier Bichat, Paris, France; University Paris-Diderot, Sorbonne Paris Cité, Laboratoire d'excellence INFLAMEX, DHU FIRE, Paris, France.
Marc BenhamouINSERM U1149, Faculté de Médecine Xavier Bichat, Paris, France; University Paris-Diderot, Sorbonne Paris Cité, Laboratoire d'excellence INFLAMEX, DHU FIRE, Paris, France.
Inserm · FRNational Institute of Arthritis and Musculoskeletal and Skin Diseases · USSorbonne Paris Cité · FRUniversité Paris Cité · FRUniversity of Rochester · USNational Institutes of Health · US

Funding

Intramural NIH HHS
6 · The paper itself

Abstract

Engagement of high-affinity immunoglobulin E receptors (FcεRI) activates two signaling pathways in mast cells. The Lyn pathway leads to recruitment of Syk and to calcium mobilization whereas the Fyn pathway leads to phosphatidylinositol 3-kinase recruitment. Mapping the connections between both pathways remains an important task to be completed. We previously reported that Phospholipid Scramblase 1 (PLSCR1) is phosphorylated on tyrosine after cross-linking FcεRI on RBL-2H3 rat mast cells, amplifies mast cell degranulation, and is associated with both Lyn and Syk tyrosine kinases. Here, analysis of the pathway leading to PLSCR1 tyrosine phosphorylation reveals that it depends on the FcRγ chain. FcεRI aggregation in Fyn-deficient mouse bone marrow-derived mast cells (BMMC) induced a more robust increase in FcεRI-dependent tyrosine phosphorylation of PLSCR1 compared to wild-type cells, whereas PLSCR1 phosphorylation was abolished in Lyn-deficient BMMC. Lyn association with PLSCR1 was not altered in Fyn-deficient BMMC. PLSCR1 phosphorylation was also dependent on the kinase Syk and significantly, but partially, dependent on detectable calcium mobilization. Thus, the Lyn/Syk/calcium axis promotes PLSCR1 phosphorylation in multiple ways. Conversely, the Fyn-dependent pathway negatively regulates it. This study reveals a complex regulation for PLSCR1 tyrosine phosphorylation in FcεRI-activated mast cells and that PLSCR1 sits at a crossroads between Lyn and Fyn pathways.

Indexed as

AnimalsCalciumCell DegranulationCell LineGene Expression RegulationIntracellular Signaling Peptides and ProteinsMast CellsMicePhosphatidylinositol 3-KinasesPhospholipid Transfer ProteinsPhosphorylationProtein-Tyrosine KinasesProto-Oncogene Proteins c-fynRatsReceptors, IgESignal TransductionCalciumFc-epsilon receptor I beta-chain, mouseFyn protein, mouseIntracellular Signaling Peptides and Proteinslyn protein-tyrosine kinasePhosphatidylinositol 3-KinasesPhospholipid Transfer ProteinsPlscr1 protein, mouseProtein-Tyrosine KinasesProto-Oncogene Proteins c-fynReceptors, IgEsrc-Family KinasesSyk KinaseSyk protein, mouseSyk protein, ratTyrosine

Identifiers

PMID25289695
PMCPMC4188579
OpenAlexW1992278117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.